Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fulgent Genetics, Inc. Director's Dealing 2020

Sep 24, 2020

32553_dirs_2020-09-23_90c05a3b-7905-409f-b29d-e8dcd929cacb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-09-11

Reporting Person: Xie Jian (Chief Operating Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 451295 Direct

Footnotes

F1: On September 14, 2020, the reporting person filed a Form 4 which inadvertently reported that, following his transfer of shares to a blind trust, he directly owned 451,736 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 451,295 shares of the issuer's common stock following such transfer.